Ghent University Academic Bibliography

Risk stratification of high-risk metastatic neuroblastoma : a report from the HR-NBL-1/SIOPEN study

Daniel A Morgenstern, Ulrike Pötschger, Lucas Moreno, Vassilios Papadakis, Cormac Owens, Shifra Ash, Claudia Pasqualini, Roberto Luksch, Alberto Garaventa, Adela Canete, et al.

(2018) PEDIATRIC BLOOD & CANCER. 65(11).

Add to list

Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia : results of the EORTC CLG 58881 and 58951 trials

C Piette, S Suciu, E Clappier, Y Bertrand, S Drunat, S Girard, K Yakouben, G Plat, N Dastugue, F Mazingue, et al.

(2018) LEUKEMIA. 32(1). p.244-248

Add to list

Journal Article
A1
open access

Prolonged versus standard native E-coli asparaginase therapy in childhood acute lymphoblastic leukemia and non-Hodgkin lymphoma : final results of the EORTC-CLG randomized phase III trial 58951

Veerle Mondelaers (UGent) , Stefan Suciu, Barbara De Moerloose (UGent) , Alina Ferster, Francoise Mazingue, Geneviève Plat, Karima Yakouben, Anne Uyttebroeck, Patrick Lutz, Vitor Costa, et al.

(2017) HAEMATOLOGICA. 102(10). p.1727-1738

Add to list

Therapy with low-dose azacitidine for MDS in children and young adults: a retrospective analysis of the EWOG-MDS study group

Annamaria M Cseh, Charlotte M Niemeyer, Ayami Yoshimi, Albert Catala, Michael C Frühwald, Henrik Hasle, Mary M van den Heuvel-Eibrink, Melchior Lauten, Barbara De Moerloose (UGent) , Owen P Smith, et al.

(2016) BRITISH JOURNAL OF HAEMATOLOGY. 172(6). p.930-936

Add to list

Clinical impact of additional cytogenetic aberrations, cKIT and RAS mutations, and treatment elements in pediatric t(8;21)-AML : results from an international retrospective study by the International Berlin-Frankfurt-Münster study group

Kim Klein, Gertjan Kaspers, Christine J Harrison, H Berna Beverloo, Ardine Reedijk, Mathilda Bongers, Jacqueline Cloos, Andrea Pession, Dirk Reinhardt, Martin Zimmerman, et al.

(2015) JOURNAL OF CLINICAL ONCOLOGY. 33(36). p.4247-4258

Add to list

A phase Ib, open-label study to assess the safety of continuous oral treatment with afatinib in combination with two chemotherapy regimens: cisplatin plus paclitaxel and cisplatin plus 5-fluorouracil, in patients with advanced solid tumors

JB Vermorken, Sylvie Rottey (UGent) , E Ehrnrooth, K Pelling, A Lahogue, S Wind and J-P Machiels

(2013) ANNALS OF ONCOLOGY. 24(5). p.1392-1400

Add to list

Cytoreduction and hyperthermic intraperitoneal chemoperfusion in women with heavily pretreated recurrent ovarian cancer

Wim Ceelen (UGent) , Yves Van Nieuwenhove (UGent) , Simon Van Belle (UGent) , Hannelore Denys (UGent) and Piet Pattyn (UGent)

(2012) ANNALS OF SURGICAL ONCOLOGY. 19(7). p.2352-2359

Add to list

Intensity-modulated arc therapy with cisplatin as neo-adjuvant treatment for primary irresectable cervical cancer : toxicity, tumour response and outcome

Katrien Vandecasteele (UGent) , Amin Makar (UGent) , Rudy Van den Broecke (UGent) , Louke Delrue (UGent) , Hannelore Denys (UGent) , Kathleen Lambein (UGent) , Bieke Lambert (UGent) , Marc Van Eijkeren (UGent) , Philippe Tummers (UGent) and Gert De Meerleer (UGent)

(2012) STRAHLENTHERAPIE UND ONKOLOGIE. 188(7). p.576-581

Add to list

Randomized trial of prophylactic granulocyte colony-stimulating factor during rapid COJEC induction in pediatric patients with high-risk neuroblastoma: the european HR-NBL1/SIOPEN study

Ruth Ladenstein, Domonique Valteau-Couanet, Penelope Brock, Isaac Yaniv, Victoria Castel, Genevieve Laureys (UGent) , Josef Malis, Vassilios Papadakis, Ana Lacerda, Ellen Ruud, et al.

(2010) JOURNAL OF CLINICAL ONCOLOGY. 28(21). p.3516-3524

Add to list

A systematic methodology review of phase I radiation dose escalation trials

Madelon Pijls-Johannesma, Ghislaine van Mastrigt, Steve M Hahn, Dirk De Ruysscher, Brigitta G Baumert, Guido Lammering, Jerone Buijsen, Soren M Bentzen, Yolande Lievens (UGent) , Andrew Kramar, et al.

(2010) RADIOTHERAPY AND ONCOLOGY. 95(2). p.135-141

Academic Bibliography

Risk stratification of high-risk metastatic neuroblastoma : a report from the HR-NBL-1/SIOPEN study

Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia : results of the EORTC CLG 58881 and 58951 trials

Prolonged versus standard native E-coli asparaginase therapy in childhood acute lymphoblastic leukemia and non-Hodgkin lymphoma : final results of the EORTC-CLG randomized phase III trial 58951

Therapy with low-dose azacitidine for MDS in children and young adults: a retrospective analysis of the EWOG-MDS study group

Clinical impact of additional cytogenetic aberrations, cKIT and RAS mutations, and treatment elements in pediatric t(8;21)-AML : results from an international retrospective study by the International Berlin-Frankfurt-Münster study group

A phase Ib, open-label study to assess the safety of continuous oral treatment with afatinib in combination with two chemotherapy regimens: cisplatin plus paclitaxel and cisplatin plus 5-fluorouracil, in patients with advanced solid tumors

Cytoreduction and hyperthermic intraperitoneal chemoperfusion in women with heavily pretreated recurrent ovarian cancer

Intensity-modulated arc therapy with cisplatin as neo-adjuvant treatment for primary irresectable cervical cancer : toxicity, tumour response and outcome

Randomized trial of prophylactic granulocyte colony-stimulating factor during rapid COJEC induction in pediatric patients with high-risk neuroblastoma: the european HR-NBL1/SIOPEN study

A systematic methodology review of phase I radiation dose escalation trials

Contents

Support

Contact